• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pharmacokinetics of tuberculosis drugs in HIV-infected patients from Irkutsk, Russian Federation: redefining drug activity.俄罗斯伊尔库茨克地区HIV感染患者抗结核药物的药代动力学：重新定义药物活性
Eur Respir J. 2018 May 24;51(5). doi: 10.1183/13993003.00109-2018. Print 2018 May.
2
Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.西伯利亚伊尔库茨克一家转诊医院中未得到充分治疗的艾滋病毒和耐药结核病。
Int J Tuberc Lung Dis. 2016 Feb;20(2):187-92. doi: 10.5588/ijtld.14.0961.
3
Adverse drug reactions during drug-resistant TB treatment in high HIV prevalence settings: a systematic review and meta-analysis.高 HIV 流行地区耐多药结核病治疗期间的药物不良反应：系统评价和荟萃分析。
J Antimicrob Chemother. 2017 Jul 1;72(7):1871-1879. doi: 10.1093/jac/dkx107.
4
Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients.耐多药结核病合并艾滋病毒感染患者中的贝达喹啉耐药性
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.02383-2019. Print 2020 Jun.
5
Multidrug-resistant tuberculosis in an HIV-infected girl.一名感染艾滋病毒女孩的耐多药结核病
Natl Med J India. 2012 Jul-Aug;25(4):210-1.
6
Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015.2000 - 2015年巴西耐多药结核病“较短”治疗方案中所用药物的耐药情况
Eur Respir J. 2017 Apr 12;49(4). doi: 10.1183/13993003.02309-2016. Print 2017 Apr.
7
Dried blood spots can help decrease the burden on patients dually infected with multidrug-resistant tuberculosis and HIV.干血斑有助于减轻同时感染耐多药结核病和艾滋病毒的患者的负担。
Eur Respir J. 2016 Sep;48(3):932-4. doi: 10.1183/13993003.00599-2016. Epub 2016 Jun 10.
8
Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.HIV 感染者与 HIV 非感染者耐药结核病治疗结局的比较：多中心队列研究。
PLoS One. 2018 Mar 8;13(3):e0193491. doi: 10.1371/journal.pone.0193491. eCollection 2018.
9
Treatment of drug-resistant tuberculosis among people living with HIV.HIV 感染者中的耐药结核病治疗。
Curr Opin HIV AIDS. 2018 Nov;13(6):478-485. doi: 10.1097/COH.0000000000000503.
10
Treatment outcomes of MDR-TB and HIV co-infection in Europe.欧洲耐多药结核病与艾滋病病毒合并感染的治疗结果
Eur Respir J. 2017 Jun 8;49(6). doi: 10.1183/13993003.02363-2016. Print 2017 Jun.

引用本文的文献

1
Urine colorimetry for levofloxacin pharmacokinetics and personalized dosing in people with drug-resistant tuberculosis.尿液比色法用于耐药结核病患者左氧氟沙星药代动力学和个体化给药。
Int J Mycobacteriol. 2020 Oct-Dec;9(4):411-416. doi: 10.4103/ijmy.ijmy_186_20.

本文引用的文献

1
Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis.治疗药物监测以预防氟喹诺酮类药物在结核病治疗中产生获得性耐药。
Eur Respir J. 2017 Apr 26;49(4). doi: 10.1183/13993003.00173-2017. Print 2017 Apr.
2
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.《世界卫生组织耐药结核病治疗指南（2016年更新版）》
Eur Respir J. 2017 Mar 22;49(3). doi: 10.1183/13993003.02308-2016. Print 2017 Mar.
3
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation.在免疫激活水平较高的人类免疫缺陷病毒/结核病患者中，异烟肼清除率受损。
Br J Clin Pharmacol. 2017 Apr;83(4):801-811. doi: 10.1111/bcp.13172. Epub 2016 Dec 9.
4
Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers.广泛耐药结核病的个体化管理：诊断、治疗及生物标志物
Expert Rev Anti Infect Ther. 2017 Jan;15(1):11-21. doi: 10.1080/14787210.2017.1247692. Epub 2016 Oct 24.
5
Incorporating therapeutic drug monitoring into the World Health Organization hierarchy of tuberculosis diagnostics.将治疗药物监测纳入世界卫生组织结核病诊断体系。
Eur Respir J. 2016 Jun;47(6):1867-9. doi: 10.1183/13993003.00040-2016. Epub 2016 Mar 17.
6
Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.西伯利亚伊尔库茨克一家转诊医院中未得到充分治疗的艾滋病毒和耐药结核病。
Int J Tuberc Lung Dis. 2016 Feb;20(2):187-92. doi: 10.5588/ijtld.14.0961.
7
Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis.左氧氟沙星在耐多药结核病患者中的空洞穿透情况。
Antimicrob Agents Chemother. 2015;59(6):3149-55. doi: 10.1128/AAC.00379-15. Epub 2015 Mar 16.
8
Quantitative drug-susceptibility in patients treated for multidrug-resistant tuberculosis in Bangladesh: implications for regimen choice.孟加拉国耐多药结核病患者的定量药物敏感性：对治疗方案选择的影响
PLoS One. 2015 Feb 24;10(2):e0116795. doi: 10.1371/journal.pone.0116795. eCollection 2015.
9
Therapeutic drug monitoring in the treatment of tuberculosis: an update.结核病治疗中的治疗药物监测：更新。
Drugs. 2014 Jun;74(8):839-54. doi: 10.1007/s40265-014-0222-8.
10
Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation.俄罗斯联邦东西伯利亚 2 个地区原发性耐多药结核分枝杆菌。
Emerg Infect Dis. 2013 Oct;19(10):1649-52. doi: 10.3201/eid1910.121108.

Pharmacokinetics of tuberculosis drugs in HIV-infected patients from Irkutsk, Russian Federation: redefining drug activity.

作者信息

Lyles Galina, Ogarkov Oleg, Zhdanova Svetlana, Peloquin Charles A, Ebers Andrew, Pfaeffle Herman, Al-Shaer Mohammad H, Moiseeva Elena, Zorkaltseva Elena, Koscheev Mikhail, Houpt Eric R, Heysell Scott K

机构信息

Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA, USA.

Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk, Russia.

出版信息

Eur Respir J. 2018 May 24;51(5). doi: 10.1183/13993003.00109-2018. Print 2018 May.

DOI:10.1183/13993003.00109-2018
PMID:29599189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6230247/
Abstract
摘要